Toll-Like Receptor 4 Plays a Central Role in Cardiac Dysfunction During Trauma Hemorrhage Shock
Open Access
- 1 July 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Shock
- Vol. 42 (1) , 31-37
Abstract
Cardiac dysfunction is a major consequence that contributes to the high mortality of trauma-hemorrhage (TH) patients. Recent evidence suggests that innate immune and inflammatory responses mediated by Toll-like receptors (TLRs) play a critical role in the pathophysiologic mechanisms of acute organ dysfunction during TH. This study investigated the role of TLR4 in cardiac dysfunction following TH. Toll-like receptor 4–deficient (TLR4−/−, n = 7/group) and age-matched wild-type (WT, n = 8/group) mice were subjected to TH that was induced by soft tissue injury and blood withdrawal from the jugular vein to a mean arterial pressure of 35 ± 5 mmHg. Cardiac function and mean arterial pressure were measured with a Millar system before, during, and after blood withdrawal. Sham surgical-operated mice served as control (WT, n = 9/group; TLR4−/−, n = 10/group). Cardiac function in WT mice was significantly reduced following TH. However, cardiac function was well preserved in TLR4−/− mice. Administration of a TLR4 antagonist (3 mg/kg) to WT mice also significantly attenuated TH-induced cardiac dysfunction. Western blot showed that either TLR4−/− or TLR4 antagonist markedly attenuated TH-induced decreases in the levels of phosphorylated-Akt in myocardium. In addition, inhibition of TLR4 attenuated TH-induced myocardial nuclear factor κB–binding activity as well as lung myeloperoxidase activity and tumor necrosis factor α production. The data indicate that TLR4 plays a central role in TH-induced cardiac dysfunction. Toll-like receptor 4 deficiency or TLR4 inhibition attenuated cardiac dysfunction following TH, which may involve activation of the phosphoinositide 3-kinase/Akt signaling and decrease in nuclear factor κB–binding activity. Toll-like receptor 4 antagonism may be a new and novel approach for the treatment and management of cardiac dysfunction in TH patients.Keywords
This publication has 34 references indexed in Scilit:
- Activation of Myocardial Phosphoinositide-3-Kinase p110α Ameliorates Cardiac Dysfunction and Improves Survival in Polymicrobial SepsisPLOS ONE, 2012
- Mechanism of cardiac depression after trauma-hemorrhage: increased cardiomyocyte IL-6 and effect of sex steroids on IL-6 regulation and cardiac functionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- PI3K and negative regulation of TLR signalingTrends in Immunology, 2003
- Akt induces enhanced myocardial contractility and cell size in vivo in transgenic miceProceedings of the National Academy of Sciences, 2002
- Calpain inhibitor I reduces the activation of nuclear factor‐κΒ and organ injury/dysfunction in hemorrhagic shockThe FASEB Journal, 2001
- Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal TransductionJournal of Biological Chemistry, 1999
- Early activation of transcription factor NF-κB during ischemia in perfused rat heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 1999
- Hemorrhage Activates Myocardial NFκB and Increases TNF-α in the HeartJournal of Molecular and Cellular Cardiology, 1997
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemie myocardiumJournal of Pharmacological Methods, 1985